February 21, 2020
Kyowa Kirin said on February 20 that it has initiated a PI clinical trial of an automated injection device for its sustained-release G-CSF preparation G-Lasta (pegfilgrastim) in Japan. The trial is a multicenter, open-label, single-arm study with safety as its...read more